|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Metastatic breast cancer;therapeutic op-tions according to molecular subtypes and prior adjuvant thera-py显示文摘 | Guameri V Conte P | 2009 | Oncologist2009，14，： | 1 |
| 2 | Double- blind, Placebo- controlled, Multicenter, Randomized, Phase iib neoadjuvant study of letrozole-lapatinib in post- menopausal hormone receptor-positive, Human epidermal growth factor receptor2-negative, Operable breast cancer 显示文摘 | Guameri V Generali DG Frassoldati A | 2014 | Clin 0ncol2014，32，10： | 1 |
| 3 | Pregnenolone biosynthesis in C6-2B glioma cell mitochondria:Regulation by a mitochondrial diazepam binding inhibitor receptor显示文摘 | Papadopoulos V Guameri P Krueger K E | | 0，，： | 1 |
| 4 | A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast caneer patients with residual disease after preoperative chemotherapy显示文摘 | Guameri V Piacentini F Ficarra G | 2009 | Ann One2009，20，7： | 1 |
| 5 | Safety of intravenous and oral bisphosphonates and compliance with dosing regimens显示文摘 | Conte P Guameri V | 2004 | Oncologist2004，9，4： | 1 |
| 6 | Energy-level statistics of integrable quantum systems 显示文摘 | Casti G Chirikov B V Guameri I | 1985 | Phys Rev Lett1985，54，： | 1 |
| 7 | Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors 显示文摘 | Guameri V Broglio K Kau SW | 2006 | J Clin 0ncol2006，24，： | 1 |
| 8 | Circulating tumorcells in metastatic breast cancer:biologic staging beyond tumorburden显示文摘 | Cristofanilli M Broglio KR Guameri V | 2007 | Clin Breast Cancer2007，7，6： | 1 |
| 9 | Comparisonof HER-2 and hormone receptor expression in primarybreast cancers and asynchronous paired metastases:impact on patient management 显示文摘 | Guameri V Giovannelli S Ficarra G | 2008 | Oncologist2008，13，8： | 1 |
| 10 | The curability of breast cancer and the treatment of advanced disease 显示文摘 | Guameri V Conte PF | 2004 | Eur J Nucl Med Mol Imaging2004，31，： | 1 |
| 11 | Metastatic breast cancer: therapeuticoptions according to molecular subtypes and prior adjuvanttherapy显示文摘 | Guameri V Conte P | 2009 | Oncologist2009，14，7： | 1 |
| 12 | Enhancing intracellular taxanedelivery : current role and perspectives of nanoparticle albumin-boundpaclitaxel in the treatment of advanced breast cancer 显示文摘 | Guameri V Dieci MV Conte P | 2012 | ExpertOpin Phannacother2012，13，3： | 1 |
| 13 | Muhicentric, randomized phase m trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278 ) 显示文摘 | Guameri V Frassoldati A Bruzzi P | 2008 | Clin Breast Cancer2008，8，5： | 1 |
| 14 | A prognostic model based on nodal status and Ki -67 predicts the risk of recurrence and death in breast cancer patients with re- sidual disease after preoperative chemotherapy 显示文摘 | Guameri V Piacentini F Ficarra G | 2009 | Ann Oncol2009，20，7： | 1 |
| 15 | Concomitant versus sequential administration of epirubiein and paclitaxel as first-line therapy in metastatic breast carcinoma: results from the Grouppo Oncologico Nord Ovest Randomized Trial显示文摘 | Conte PF Guameri V Bruzzi P | 2004 | Cancer2004，101，4： | 1 |
| 16 | A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy显示文摘 | Guameri V | 2009 | Ann Oncol2009，20，7： | 1 |
| 17 | Prolonged fixed dose rateinfusion of gemcitabine with autologous haemopoietic support in ad-vanced pancreatic adenocarcinoma显示文摘 | Bengala C Guameri V Giovannetti E | 2005 | Br J Cancer2005，93，： | 1 |
| 18 | Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘 | Guameri V Broglio K Kau SW | | 0，，07： | 1 |
| 19 | Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factots显示文摘 | Guameri V Broglio K Kau SW | | 0，，07： | 1 |
| 20 | Tumor size, node status,grading, Her- 2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent year显示文摘 | Cortesi L Marcheselli L Guameri V | 2013 | Int J Cancer2013，132，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员